Assessment of liver function for safe hepatic resection

The preoperative assessment of liver function is extremely important for preventing postoperative liver failure and mortality after hepatic resection. Liver function tests may be divided into three types; conventional liver function tests, general scores, and quantitative liver function tests. General scores are based on selected clinical symptoms and conventional test results. Child–Turcotte–Pugh score has been the gold standard for four decades, but the Child–Turcotte–Pugh score has difficulty discriminating a good risk from a poor risk in patients with mild to moderate liver dysfunction. The model for end‐stage liver disease score has also been applied to predict short‐term outcome after hepatectomy, but it is only useful in patients with advanced cirrhosis. Quantitative liver function tests overcome the drawbacks of general scores. The indocyanine green retention rate at 15 minutes (ICG R15) has been reported to be a significant predictor of postoperative liver failure and mortality. The safety limit of the hepatic parenchymal resection rate can be estimated using the ICG R15, and a decision tree (known as the Makuuchi criteria) for selecting patients and hepatectomy procedures has been proposed. Hepatic resection can be performed with a mortality rate of nearly zero using this decision tree. If the future remnant liver volume does not fulfill the Makuuchi criteria, preoperative portal vein embolization should be performed to prevent postoperative liver failure. Galactosyl human serum albumin‐diethylenetriamine‐pentaacetic acid scintigraphy also provides data that complement the ICG test. Other quantitative liver function tests, however, require further validation and simplification.

[1]  O. Garden,et al.  An 8‐year experience of hepatic resection: indications and outcome , 1998, The British journal of surgery.

[2]  T. Pawlik,et al.  Chemotherapy‐associated hepatotoxicity and surgery for colorectal liver metastases , 2007, The British journal of surgery.

[3]  Yutaka Matsuyama,et al.  Development of evidence‐based clinical guidelines for the diagnosis and treatment of hepatocellular carcinoma in Japan , 2008, Hepatology research : the official journal of the Japan Society of Hepatology.

[4]  A. Sugioka,et al.  Hepatic resection for hepatocellular carcinoma. , 1990, Surgery.

[5]  M. Makuuchi,et al.  One thousand fifty-six hepatectomies without mortality in 8 years. , 2003, Archives of surgery.

[6]  G. Gerken,et al.  Quantitative liver function tests in donors and recipients of living donor liver transplantation , 2006, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[7]  Norio Nakao,et al.  A novel 3D hepatectomy simulation based on liver circulation: Application to liver resection and transplantation , 2005, Hepatology.

[8]  K Torizuka,et al.  [Phase I clinical study on 99mTc-GSA, a new agent for functional imaging of the liver]. , 1991, Kaku igaku. The Japanese journal of nuclear medicine.

[9]  S. Kawasaki,et al.  Preoperative portal vein embolization: An audit of 84 patients , 1999, Hepatology.

[10]  S. Cha,et al.  Hepatic resection of hepatocellular carcinoma in patients with cirrhosis: Model of end-stage liver disease (MELD) score predicts perioperative mortality , 2005, Journal of Gastrointestinal Surgery.

[11]  H. Petrowsky,et al.  Strategies for safer liver surgery and partial liver transplantation. , 2007, The New England journal of medicine.

[12]  M. Makuuchi,et al.  Preoperative portal embolization to increase safety of major hepatectomy for hilar bile duct carcinoma: a preliminary report. , 1990, Surgery.

[13]  S. Saleh,et al.  Antipyrine clearance in comparison to conventional liver function tests in hepatitis C virus patients. , 2007, European journal of pharmacology.

[14]  C. Scudamore,et al.  Indocyanine green clearance as a predictor of successful hepatic resection in cirrhotic patients. , 1992, American journal of surgery.

[15]  E. Abdalla,et al.  Portal vein embolization before major hepatectomy and its effects on regeneration, resectability and outcome , 2007, The British journal of surgery.

[16]  J. Bruix,et al.  Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure. , 1996, Gastroenterology.

[17]  T. Eberlein Hepatic Insufficiency and Mortality in 1,059 Noncirrhotic Patients Undergoing Major Hepatectomy , 2008 .

[18]  M. Makuuchi,et al.  The role of preoperative phenylalanine breath test in hepatectomy. , 2003, Hepato-gastroenterology.

[19]  Y Bandai,et al.  Asialoglycoprotein receptor and hepatic blood flow using technetium-99m-DTPA-galactosyl human serum albumin. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[20]  M. Makuuchi,et al.  Measurement of liver volume and hepatic functional reserve as a guide to decision‐making in resectional surgery for hepatic tumors , 1997, Hepatology.

[21]  C. G. Child,et al.  Surgery and portal hypertension. , 1964, Major problems in clinical surgery.

[22]  T. Muto,et al.  Predictors of successful hepatic resection: Prognostic usefulness of hepatic asialoglycoprotein receptor analysis , 2002, World Journal of Surgery.

[23]  M. Fried,et al.  13C‐methacetin breath test as a quantitative liver function test in patients with chronic hepatitis C infection: continuous automatic molecular correlation spectroscopy compared to isotopic ratio mass spectrometry , 2007, Alimentary pharmacology & therapeutics.

[24]  T. Utsunomiya,et al.  Postoperative liver failure after major hepatic resection for hepatocellular carcinoma in the modern era with special reference to remnant liver volume. , 1999, Journal of the American College of Surgeons.

[25]  S. Curley,et al.  Hepatic insufficiency and mortality in 1,059 noncirrhotic patients undergoing major hepatectomy. , 2007, Journal of the American College of Surgeons.

[26]  T M Therneau,et al.  A model to predict survival in patients with end‐stage liver disease , 2001, Hepatology.

[27]  M. Vivarelli,et al.  Recovery from liver failure after hepatectomy for hepatocellular carcinoma in cirrhosis: meaning of the model for end-stage liver disease. , 2006, Journal of the American College of Surgeons.

[28]  M. Makuuchi,et al.  Three-dimensional computed tomography for planning donor hepatectomy. , 2007, Transplantation proceedings.

[29]  K Torizuka,et al.  [Phase II clinical study on 99mTc-GSA, a new agent for functional imaging of the liver]. , 1991, Kaku igaku. The Japanese journal of nuclear medicine.

[30]  T. Sato,et al.  Recovery of hepatic asialoglycoprotein receptors after major hepatic resection. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[31]  O. Farges,et al.  Seven hundred forty-seven hepatectomies in the 1990s: an update to evaluate the actual risk of liver resection. , 2000, Journal of the American College of Surgeons.

[32]  R. Pugh,et al.  Transection of the oesophagus for bleeding oesophageal varices , 1973, The British journal of surgery.

[33]  R. Wiesner,et al.  Model for end-stage liver disease (MELD) and allocation of donor livers. , 2003, Gastroenterology.

[34]  T. Nagayasu,et al.  Relationship between indocyanine green test and technetium-99m galactosyl serum albumin scintigraphy in patients scheduled for hepatectomy: Clinical evaluation and patient outcome. , 2004, Hepatology research : the official journal of the Japan Society of Hepatology.

[35]  S. Kawasaki,et al.  Surgery for small liver cancers. , 1993, Seminars in surgical oncology.

[36]  F. Chang,et al.  Proposal of a modified Child‐Turcotte‐Pugh scoring system and comparison with the model for end‐stage liver disease for outcome prediction in patients with cirrhosis , 2006, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[37]  M. Makuuchi,et al.  Assessment of hepatic reserve for indication of hepatic resection: decision tree incorporating indocyanine green test. , 2005, Journal of hepato-biliary-pancreatic surgery.

[38]  S. Fan,et al.  Hospital mortality of major hepatectomy for hepatocellular carcinoma associated with cirrhosis. , 1995, Archives of surgery.

[39]  P O Scheibe,et al.  Measurement of receptor concentration and forward-binding rate constant via radiopharmacokinetic modeling of technetium-99m-galactosyl-neoglycoalbumin. , 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[40]  N. Yamanaka,et al.  Prediction of the safe limits of hepatectomy by combined volumetric and functional measurements in patients with impaired hepatic function. , 1994, Cancer treatment and research.

[41]  S K Ha-Kawa,et al.  A quantitative model of technetium-99m-DTPA-galactosyl-HSA for the assessment of hepatic blood flow and hepatic binding receptor. , 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[42]  W. Hawkins,et al.  Effect of steatohepatitis associated with irinotecan or oxaliplatin pretreatment on resectability of hepatic colorectal metastases. , 2005, Journal of the American College of Surgeons.

[43]  J. Bruix,et al.  Prognosis of Hepatocellular Carcinoma: The BCLC Staging Classification , 1999, Seminars in liver disease.

[44]  M. Makuuchi,et al.  Report of the 16th follow-up survey of primary liver cancer. , 2005, Hepatology research : the official journal of the Japan Society of Hepatology.

[45]  M. Büchler,et al.  Preoperative Galactose Elimination Capacity Predicts Complications and Survival After Hepatic Resection , 2002, Annals of surgery.

[46]  M. Makuuchi,et al.  Long-Term Outcome of Extended Hemihepatectomy for Hilar Bile Duct Cancer With No Mortality and High Survival Rate , 2003, Annals of surgery.

[47]  P. Kamath,et al.  A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts , 2000, Hepatology.

[48]  S. Orloff,et al.  Model for End-stage Liver Disease score fails to predict perioperative outcome after hepatic resection for hepatocellular carcinoma in patients without cirrhosis. , 2008, American journal of surgery.

[49]  K. Man,et al.  Evaluation of preoperative hepatic function in patients with hepatocellular carcinoma undergoing hepatectomy , 1997, The British journal of surgery.

[50]  R. Schulick Assessment of Liver Function in the Surgical Patient , 2007 .

[51]  D. Vera,et al.  Evaluation of hepatocellular function by way of receptor‐mediated uptake of a technetium‐99m—labeled asialoglycoprotein analog , 1994, Hepatology.

[52]  J. Meakins,et al.  Resection of hepatocellular carcinomas. Results in 72 European patients with cirrhosis. , 1990, Gastroenterology.

[53]  D. Nagorney,et al.  Predictive indices of morbidity and mortality after liver resection. , 2006, Annals of surgery.

[54]  M. Makuuchi,et al.  Sequential preoperative arterial and portal venous embolizations in patients with hepatocellular carcinoma. , 2004, Archives of surgery.

[55]  K. Do,et al.  Standardized measurement of the future liver remnant prior to extended liver resection: methodology and clinical associations. , 2000, Surgery.

[56]  T. Pawlik,et al.  Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[57]  M. Makuuchi,et al.  Clinical application of TcGSA. , 2003, Nuclear medicine and biology.

[58]  S. Kawasaki,et al.  Criteria for safe hepatic resection. , 1995, American journal of surgery.

[59]  Y. Matsui,et al.  Preoperative regional maximal removal rate of technetium-99m-galactosyl human serum albumin (GSA-Rmax) is useful for judging the safety of hepatic resection. , 2006, Surgery.